The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects
Open Access
- 1 April 1994
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 51 (1) , 63-74
- https://doi.org/10.1016/0167-0115(94)90136-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The effect of age on insulin response and glucose utilization during four hyperglycemic plateausExperimental Gerontology, 1993
- Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic SubjectsDiabetes Care, 1992
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANPublished by Elsevier ,1987
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.Journal of Clinical Investigation, 1987
- Mutations in the guinea pig preproglucagon gene are restricted to a specific portion of the prohormone sequenceFEBS Letters, 1986
- Molecular forms of glucagon‐like peptides in manFEBS Letters, 1985
- Hamster preproglucagon contains the sequence of glucagon and two related peptidesNature, 1983
- Feedback Inhibition of Insulin Secretion by Insulin: Relation to the Hyperinsulinemia of ObesityNew England Journal of Medicine, 1982
- The incretin concept todayDiabetologia, 1979
- Oral Glucose Augmentation of Insulin SecretionJournal of Clinical Investigation, 1978